Civica Plans Chesterfield County, Virginia, Laboratory Facility
09/09/2022
The company will construct a 55,000-square-foot facility to support its Petersburg pharmaceutical manufacturing operation through quality testing and development of new products. In addition, Civic will host a scale-up manufacturing facility operated by Virginia Commonwealth University’s Medicines for All Institute.
“With this investment, Civica is building on its long-term commitment to patients, and to Virginia,” said Ned McCoy, Civica’s President and CEO. “This lab will support a skilled and highly trained workforce who will ensure Civica’s affordable insulin as well as other essential medicines meet the highest standards.”.
The construction of the lab will be supported by an award from the U.S. Economic Development Administration to the Alliance for Building Better Medicine, a coalition that aims to expand essential medicines manufacturing in the Richmond-Petersburg region. Civica will provide matching capital..
“Civica’s investment is another transformational step forward in strengthening the advanced pharmaceutical?manufacturing hub in the Richmond-Petersburg region and positioning Virginia as a key player in domestic drug manufacturing in America,” added Governor Glenn Youngkin. “Civica is a critical partner in the Commonwealth’s emerging pharmaceutical ecosystem that will ensure access to affordable, lifesaving medications while providing high-quality jobs and an incredible boost to our economy.”.
The Virginia Economic Development Partnership (VEDP) worked with Chesterfield County to secure the project and Youngkin approved a $400,000 grant to the county for assistance. The Virginia Talent Accelerator Program will help with recruitment and training for the new jobs. In addition, Chester-based Brightpoint Community College has created a training program to help people gain qualifications for manufacturing technician jobs at the upcoming Civica Petersburg plant.
“Civica’s new laboratory testing facility in Chesterfield County extends the footprint of the rapidly growing pharmaceutical manufacturing cluster in the region and will support the coalition’s long-term vision to serve as the world’s central access point for advanced pharmaceutical manufacturing and R&D,” said Secretary of Commerce and Trade Caren Merrick. “Today we celebrate Virginia’s vital role in addressing the shortage of affordable essential medicines in our nation and the investment in a new facility that will create high-paying jobs and accelerate research and innovation in the industry.”
Civica Rx is a nonprofit generic drug company founded in 2018 by national philanthropies and leading U.S. health systems to reduce and prevent drug shortages in the United States and the price spikes that can accompany them.
Project Announcements
DePre Plans Powell, Tennessee, Production Operations
09/25/2023
Boyd Metals Expands Joplin, Missouri, Operations
09/25/2023
Books for Less Plans Westminster, South Carolina, Distribution Hub
09/25/2023
Lyon Shipyard Expands Norfolk, Virginia, Operations
09/25/2023
Silfab Solar Plans Fort Mill, South Carolina, Manufacturing Operations
09/25/2023
Eaton Expands El Paso, Texas, Operations
09/22/2023
Most Read
-
2023 Top States for Doing Business Meet the Needs of Site Selectors
Q3 2023
-
2022 Top States for Doing Business Provide an Environment for Business Growth
Q3 2022
-
Why the Southeast Is Winning EV Projects, With More on the Way
Q3 2023
-
EV Impacts to Watch in 2023 and 2024
2023 Auto/Aero Site Guide
-
EV and Semiconductor Projects Stand Out in States Receiving Area Development’s 18th Annual Shovel Awards
Q2 2023
-
Power-Intensive Site Selection
Q3 2023
-
37th Annual Corporate Survey: Economic Pressures Exerting Greatest Effect on Decision-Makers
Q1 2023